Skip to content

13F-HR filed by Endurant Capital Management LP

Endurant Capital Management LP filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 65 holding rows worth $230,616,000.

Accession
0001633055-18-000003
Filed
2018-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2018

A holdings report, 65 entries on the cover page, a total value of $230,616,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $230,616,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALLERGAN PLCG0177J108SHS115,072$19,185,000thousands by filing date
Merck & Co.,Inc.58933Y105COM258,073$15,665,000thousands by filing date
Abbott Laboratories002824100COM255,807$15,602,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO67,893$11,460,000thousands by filing date
CIGNA CORPORATION125509109COM64,461$10,955,000thousands by filing date
Medtronic PlcG5960L103COM124,724$10,678,000thousands by filing date
DAVITA INC COM23918K108Stock138,676$9,630,000thousands by filing date
Elevance Health, Inc.036752103COM36,936$8,792,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock64,241$7,159,000thousands by filing date
Johnson & Johnson478160104COM58,627$7,114,000thousands by filing date
CVS Health Corporation126650100COM107,073$6,890,000thousands by filing date
MYLAN NVN59465109SHS EURO179,275$6,479,000thousands by filing date
BAXTER INTL INC071813109COM80,229$5,924,000thousands by filing date
Gilead Sciences,Inc.375558103COM82,863$5,870,000thousands by filing date
CELGENE CORP151020104COM71,205$5,655,000thousands by filing date
TIVITY HEALTH INC88870R102COM159,692$5,621,000thousands by filing date
AETNA INC NEW00817Y108COM29,197$5,358,000thousands by filing date
UnitedHealth Group Inc91324P102COM16,867$4,138,000thousands by filing date
BECTON DICKINSON & CO075887109COM16,866$4,040,000thousands by filing date
HILL ROM HLDGS INC431475102COM42,877$3,745,000thousands by filing date
HOLOGIC INC436440101COM83,656$3,325,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock32,945$3,289,000thousands by filing date
HCA Healthcare Inc40412C101COM30,755$3,155,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS108,258$2,810,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock22,457$2,503,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK40,788$2,413,000thousands by filing date
Boston Scientific Corporation101137107COM72,841$2,382,000thousands by filing date
THE COOPER COMPANIES216648402COM NEW9,442$2,223,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock17,611$2,170,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS156,869$2,022,000thousands by filing date
SABRA HEALTH CARE REIT INC COM78573L106REIT90,922$1,976,000thousands by filing date
SYNEOS HEALTH INC87166B102CL A39,198$1,838,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock5,300$1,828,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock29,411$1,819,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM23,290$1,798,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM29,148$1,749,000thousands by filing date
MCKESSON CORP COM58155Q103Stock12,779$1,705,000thousands by filing date
Stryker Corporation863667101COM9,360$1,581,000thousands by filing date
ENDOLOGIX INC29266SAA4NOTE 2.250%12/11,541,000$1,518,000thousands by filing date
PRA HEALTH SCIENCES INC69354M108COM15,068$1,407,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM30,500$1,387,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock81,416$1,366,000thousands by filing date
Pfizer Inc.717081103COM34,152$1,239,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM46,929$1,091,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM142,775$964,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM82,572$936,000thousands by filing date
Mallinckrodt PlcG5785G107SHS48,725$909,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM6,714$887,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM54,504$851,000thousands by filing date
NEVRO CORP64157F103COM10,096$806,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock20,803$786,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM3,407$706,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM114,110$680,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK68,265$664,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM60,499$574,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM71,801$530,000thousands by filing date
PEDIATRIX MEDICAL GROUP INC58502B106COM9,442$409,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM7,900$386,000thousands by filing date
AKARI THERAPEUTICS PLC00972G108ADR180,297$352,000thousands by filing date
HERON THERAPEUTICS INC427746102COM8,824$343,000thousands by filing date
CENCORA INC COM03073E105Stock3,692$315,000thousands by filing date
CLEARSIDE BIOMEDICAL INC185063104COM29,400$314,000thousands by filing date
ZOGENIX INC.98978L204Common Stock6,473$286,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW1,249$224,000thousands by filing date
Ocugen43358V109Common56,177$140,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001633055-18-000003this filing2018-08-14acceptance time not in the bulk data set